Advertisement

Biotechnology Letters

, Volume 35, Issue 11, pp 1845–1852 | Cite as

Autoprocessing: an essential step for expression and purification of enterovirus 71 3Cpro in Escherichia coli

  • Shuqiong Huang
  • Yanning Lyu
  • Xianyun Qing
  • Weiwei Wang
  • Liang Tang
  • Kedi Cheng
  • Wei Wang
Original Research Paper

Abstract

A gene encoding the 3BC of human enterovirus 71 (EV71) was cloned and inserted into a derivative of plasmid pET-32a(+) driven by T7 promoter. The expressed 3C protease (3Cpro) autocatalytically cleaved itself from the recombinant protein Trx-3BC and the mature 3Cpro partitioned in the soluble fraction of bacterial lysate. The 13-amino-acid peptide substrates with the junction of 3B/3C were used to verify the proteolysis activity of the purified 3Cpro. The EV71 3Cpro had a Km value of 63 μM (measured by a continuous fluorescence assay). The other solid-phase activity assay of the EV71 3Cpro was developed using HPLC to analyze the proteolytic products. The combination of two activity assays contributes to promote the identification of the specific inhibitors targeted to the EV71 3Cpro.

Keywords

Autoprocessing Enterovirus 71 3C protease pET Trx fusion system Solid-phase activity assay Virus expression Virus purification 

Notes

Acknowledgments

This study was financially supported by the National Science Foundation of China (Grant Nos. 30772677, 81072562); the Fundamental Research Funds for the Central Universities (Grant No. 2012N06); the National Science and Technology Project of China (Grant No. 2012ZX09301002).

Supplementary material

10529_2013_1284_MOESM1_ESM.pdf (530 kb)
Supplementary material 1 (PDF 529 kb)

References

  1. Annis DA, Nickbarg E, Yang X, Ziebell MR, Whitehurst CE (2007) Affinity selection-mass spectrometry screening techniques for small molecule drug discovery. Curr Opin Chem Biol 11:518–526PubMedCrossRefGoogle Scholar
  2. Birch GM, Black T, Malcolm SK, Lai MT, Zimmerman RE, Jaskunas SR (1995) Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli. Prot Expr Purif 6:609–618CrossRefGoogle Scholar
  3. Chang LY, Huang YC, Lin TY (1998) Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352:367–368PubMedCrossRefGoogle Scholar
  4. Cordingley MG, Register RB, Callahan PL, Garsky VM, Colonno RJ (1989) Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol 63:5037–5045PubMedGoogle Scholar
  5. Cui S, Wang J, Fan T, Qin B, Guo L, Lei X, Wang J, Wang M, Jin Q (2011) Crystal structure of human enterovirus 71 3C protease. J Mol Biol 408:449–461PubMedCrossRefGoogle Scholar
  6. Jenny RJ, Mann KG, Lundblad RL (2003) A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa. Prot Expr Purif 31:1–11CrossRefGoogle Scholar
  7. Jonker N, Kool J, Irth H, Niessen WM (2011) Recent developments in protein-ligand affinity mass spectrometry. Anal Bioanal Chem 399:2669–2681PubMedCrossRefGoogle Scholar
  8. Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, Liu HG, Tseng SN, Chang SC, Lee CY, Shih SR, Liang PH (2008) Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem 16:7388–7398PubMedCrossRefGoogle Scholar
  9. McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91–107PubMedCrossRefGoogle Scholar
  10. Miyashita K, Kusumi M, Utsumi R, Komano T, Satoh N (1992) Expression and purification of recombinant 3C proteinase of Coxsackievirus B3. Biosci Biotechnol Biochem 56:746–750PubMedCrossRefGoogle Scholar
  11. Shih SR, Chiang C, Chen TC, Wu CN, Hsu JT, Lee JC, Hwang MJ, Li ML, Chen GW, Ho MS (2004) Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci 11:239–248PubMedCrossRefGoogle Scholar
  12. Ventoso I, Barco A, Carrasco L (1998) Mutational analysis of poliovirus 2Apro: distinct inhibitory functions of 2Apro on translation and transcription. J Biol Chem 273:27960–27967PubMedCrossRefGoogle Scholar
  13. Walls D, Loughran ST (2011) Tagging recombinant proteins to enhance solubility and aid purification. Methods Mol Biol 681:151–175PubMedCrossRefGoogle Scholar
  14. Weng KF, Li ML, Hung CT, Shih SR (2009) Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5:1–13CrossRefGoogle Scholar
  15. Yi L, Lu J, Kung HF, He ML (2011) The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37:313–327PubMedCrossRefGoogle Scholar
  16. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, Mao N, Xu S, Zhu S, Cui A, Zhang Y, Yan D, Li Q, Dong X, Zhang J, Zhao Y, Wan J, Feng Z, Sun J, Wang S, Li D, Xu W (2010) An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7:94PubMedCrossRefGoogle Scholar
  17. Zhang X, Song Z, Qin B, Zhang X, Chen L, Hu Y, Yuan Z (2013) Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res 97:264–269PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Shuqiong Huang
    • 1
  • Yanning Lyu
    • 2
  • Xianyun Qing
    • 3
  • Weiwei Wang
    • 3
  • Liang Tang
    • 1
  • Kedi Cheng
    • 1
  • Wei Wang
    • 1
  1. 1.Key Laboratory of Biosynthesis of Natural Products, State Key Laboratory of Bioactive Substances and Functions of Natural MedicinesInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Ministry of Health of PRCBeijingChina
  2. 2.Institute for Infectious Disease and Endemic Disease Prevention and ControlBeijing Center for Disease Prevention and ControlBeijingChina
  3. 3.College of Life ScienceQufu Normal UniversityQufuChina

Personalised recommendations